Drug Trial Radar · NCT04951076
A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)
Last checked: Nov 19, 2026Latest source record: Feb 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
212
Actual
Start
Jul 27, 2021
Primary completion
Jul 25, 2023
Study completion Aug 14, 2023
Sponsor
- Lead sponsor
- Bionomics LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jul 6, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the effects of BNC210 compared to placebo on Post-Traumatic Stress Disorder (PTSD) symptom severity as measured by the Clinician Administered PTSD scale for The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (CAPS-5) Total Symptom Severity Scores.
Conditions
- Post-Traumatic Stress Disorder
Interventions
BNC210Drug
BNC210 900 mg twice daily (b.i.d.) for 12 weeks
PlaceboDrug
Placebo twice daily (b.i.d.) for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline on the Clinician Administered Post-Traumatic Stress Disorder (PTSD) Scale for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (CAPS-5) Total Symptom Severity Scores After 12 WeeksTime frame: Baseline, 4 weeks, 8 weeks,12 weeks
Locations
32 sites in 2 countries. Site status is shown where the registry gives one.
ATTUNE Study Clinical Trial Site
Bellflower, California
ATTUNE Study Clinical Trial Site
Beverly Hills, California
ATTUNE Study Clinical Trial Site
Colton, California
ATTUNE Study Clinical Trial Site
Oceanside, California
ATTUNE Study Clinical Trial Site
Orange, California
ATTUNE Study Clinical Trial Site
Temecula, California
ATTTUNE Study Clinical Trial Site
Jacksonville, Florida
ATTUNE Study Clinical Trial Site
Lauderhill, Florida
ATTUNE Study Clinical Trial Site
Miami Lakes, Florida
ATTUNE Study Clinical Trial Site
Orlando, Florida
ATTUNE Study Clinical Trial Site
Overland Park, Kansas
ATTUNE Study Clinical Trial Site
Prairie Village, Kansas
ATTUNE Study Clinical Trial Site
New Bedford, Massachusetts
ATTUNE Study Clinical Trial Site
Las Vegas, Nevada
ATTUNE Study Clinical Trial Site
Berlin, New Jersey
ATTUNE Study Clinical Trial Site
Cherry Hill, New Jersey
ATTUNE Study Clinical Trial Site
Cedarhurst, New York
ATTUNE Study Clinical Trial Site
Staten Island, New York
ATTUNE Study Clinical Trial Site
North Canton, Ohio
ATTUNE Study Clinical Trial Site
Oklahoma City, Oklahoma
ATTUNE Study Clinical Trial Site
West Chester, Pennsylvania
ATTUNE Study Clinical Trial Site
Memphis, Tennessee
ATTUNE Study Clinical Trial Site
Austin, Texas
ATTUNE Study Clinical Trial Site
Dallas, Texas
ATTUNE Study Clinical Trial Site
Draper, Utah
ATTUNE Study Clinical Trial Site
Barnsley, United Kingdom
ATTUNE Study Clinical Trial Site
Blackpool, United Kingdom
ATTUNE Study Clinical Trial Site
Cannock, United Kingdom
ATTUNE Study Clinical Trial Site
Leeds, United Kingdom
ATTUNE Study Clinical Trial Site
Liverpool, United Kingdom
ATTUNE Study Clinical Trial Site
Manchester, United Kingdom
ATTUNE Study Clinical Trial Site
Stockton-on-Tees, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.